TRAIL and interferon-alpha act synergistically to induce renal cell carcinoma ... - UroToday PDF Print
UroTodayDespite modern targeted therapy metastatic renal cell carcinoma remains a deadly disease. Interferon-alpha (Calbiochem(R)) is currently used to treat this

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.